Scientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024. Mr. Nicols replaces Mr. John A. Moore as Chairman of SBI. Mr. John Nicols brings over three decades of experience in delivering sustained growth and value creation across diverse global businesses, from cutting-edge biotechnologies to traditional chemistry.

He is the former president and CEO of Codexis, where he led the growth and transformation of Codexis into a leading synthetic biology company. From 2013 to 2022, Nicols grew Codexis' product sales nine-fold to exceed $100 million, commercializing dozens of new products across pharmaceutical, food and nutrition, and life science tools verticals. Prior to Codexis, Nicols held various executive roles spanning his 22 years at Albemarle Corp, where he grew their largest business unit to more than $1 billion in global sales.

Nicols received a M.B.A. from the Massachusetts Institute of Technology and a B.S. degree in chemical engineering from the Polytechnic Institute of New York University. Mr. Nicols is a NACD Director Certified Board partner, and he currently serves as Chair of both Antheia, a synthetic biology-based producer for the pharmaceutical industry, and Solve M.E., a leading not-for-profit seeking cures for debilitating infection associated chronic diseases like ME/CFS and Long Covid.